Omschrijving

This book focuses on important decision points and evidence needed for making decisions at these points during the development of a new drug. It takes a holistic approach towards drug development by incorporating explicitly knowledge learned from the earlier part of the development and available historical information into decisions at later stages. In addition, the book shares lessons learned from several select examples published in the literature since the publication of the first edition. The second edition reiterates the need for making evidence-based Go/No Go decisions in drug development discussed in the first edition. It substantially expands several topics that have seen great advances since the publication of the first edition. The most noticeable additions include three adaptive

Kenmerken

Artikelnummer9300000074522191
EAN9783030797317
CategorieDigital Reading
ProductgroepBoeken
SegmentTextual/Printed/Reference Materials
Prijs Nederland€ 48,99
Prijs België€ 48,99
Verzendkosten NLGratis
Verzendkosten BEGratis
Levertijd NederlandMorgen in huis
Levertijd BelgiëMorgen in huis
VerkoperPartner

Springer Series in Pharmaceutical Statistics - Quantitative Decisions in Drug Development bestellen bij snelkeus

Koop Springer Series in Pharmaceutical Statistics - Quantitative Decisions in Drug Development van Onbekend online in de categorie Digital Reading. Prijs € 48,99, levering in Nederland · Morgen in huis.